The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMYT.L Regulatory News (AMYT)

  • There is currently no data for AMYT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of General Meeting

28 Aug 2015 15:31

RNS Number : 5121X
Fastnet Oil & Gas PLC
28 August 2015
 

28 August 2015

 

Fastnet Oil & Gas plc

("Fastnet" or the "Company")

Result of General Meeting, change of name and resignation of a Director

 

Fastnet (AIM: FAST, ESM: FOI), announces that at its General Meeting held earlier today at the Conrad London St James, 22-28 Broadway, London SW1H 0BH, the ordinary resolution approving the Investing Policy, along with the special resolution approving the change of name to Fastnet Equity plc, were duly passed. The voting in respect of each resolution was as follows:

 

Resolution

Number of votes for the resolution1

For

(%)1, 2

Number of votes against the resolution

Against

(%)2

Number of votes withheld3

To approve the Investing Policy

65,852,686

99.92

51,090

0.08

4,664,393

that the Company's name be changed to Fastnet Equity plc

65,854,751

99.93

49,025

0.07

4,664,393

 

Notes:

1. Proxy appointments totalling 192,873 shares gave discretion to the Chairman of the General Meeting and have been included in the "For" total of the appropriate resolution.

2. The number of shares in issue at 6.00 p.m. on 26 August 2015 was 345,369,071.

3. A vote "Withheld" is not a vote in law and is not counted in the calculation of the proportion of the votes "For" and "Against" a resolution.

 

Change of name

Dealings under the name "Fastnet Equity plc" are expected to commence at 8.00 am on Tuesday 1 September 2015. On change of the Company's name the Company's website will be www.fastnetequity.com.

 

Directorate change

As set out in the shareholder circular, following approval of the Proposals at today's General Meeting, Carol Law has today resigned as a director of the Company. Carol will continue as a consultant to the Company as she serves out her three month notice period.

 

Further announcements on the appointment of additional directors with life science experience will be made in due course.

 

Capitalised but undefined terms shall have the meaning given to them in the definitions appearing in the circular.

Cathal Friel, Non-Executive Chairman of Fastnet, commented:

"The Board is grateful for the support of the overwhelming majority of Shareholders, many of whom have suffered from the malaise in the oil industry as have the Board as significant Shareholders. The Board will work tirelessly to source Shareholder accretive deals for the Company in the healthcare sector and looks forward to updating shareholders on progress in the months ahead.

In terms of the Company's Celtic Sea Assets and 3D seismic survey data the Board will continue to examine all options to secure value for Shareholders. Options under consideration include spinning the Celtic Sea Assets into a stand-alone entity. This would enable any value creating opportunities from Celtic Sea Assets to benefit our existing Shareholders who would become shareholders in the newco."

 

For further information please contact:

Fastnet Oil & Gas plc

+353 (1) 644 0007

Cathal Friel, Non-Executive Chairman

Shore Capital

+44 (0) 20 7408 4090

Nomad

Bidhi Bhoma, Edward Mansfield

Corporate Broking

Jerry Keen

Davy

+353 (1) 679 6363

(ESM Adviser & Joint Broker)

John Frain, Anthony Farrell

Camarco

+44 (0) 20 3757 4980

Billy Clegg, Georgia Mann

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ROMPKFDNQBKDDFB
Date   Source Headline
7th Jan 20197:00 amRNSPositive results for gene therapy AP103
4th Jan 201912:56 pmRNSEASE Phase III trial interim efficacy results
21st Dec 20182:05 pmRNSSecond Price Monitoring Extn
21st Dec 20182:00 pmRNSPrice Monitoring Extension
19th Dec 20187:00 amRNSUpdate on ongoing AP101 Trial
10th Dec 201811:30 amRNSGrant Funding from Irish Government for AP103
17th Oct 20187:00 amRNSLojuxta to be reimbursed in France
26th Sep 20187:00 amRNSInterim Results
14th Sep 20187:00 amRNSNotice of Results
10th Sep 20187:00 amRNSAmryt receives IND approval from FDA for AP101
2nd Aug 20187:00 amRNSFDA grants Pediatric Rare Disease designation
19th Jul 20187:00 amRNSTrading update & significant momentum building
9th Jul 20187:00 amRNSNHS England approves funding for Lojuxta
6th Jul 20187:00 amRNSChange of Registered Address
25th Jun 20188:10 amRNSCompany name alteration for previous release
25th Jun 20187:00 amRNSPositive data of Pollinex Quattro Grass vaccine
5th Jun 201810:41 amRNSResult of AGM
29th May 20187:00 amRNSFour Middle East Lojuxta® Distribution Agreements
10th May 20187:00 amRNSExclusive Lojuxta® Licence Expanded
9th May 20182:48 pmRNSHolding(s) in Company
8th May 20187:00 amRNSHolding(s) in Company and Lock-in agreement
4th May 20187:00 amRNSPosting of Annual Report 2017 and Notice of AGM
17th Apr 20187:00 amRNSFinal Results
15th Mar 20187:00 amRNSTrading update & Gene therapy agreement
6th Mar 20187:00 amRNSSenior Management Appointment
6th Mar 20187:00 amRNSDistribution Agreement for Lojuxta in Middle East
2nd Mar 20187:00 amRNSNotice of Trading Update
30th Jan 20187:00 amRNSNew Distribution Agreement Signed
24th Jan 20187:00 amRNSSenior Management Team Appointment
10th Jan 20187:00 amRNSNew Distribution Agreement Signed
8th Jan 20187:00 amRNSDistribution Agreement Signed Covering Switzerland
20th Dec 20177:00 amRNSSenior Management Team Appointment
1st Dec 20177:00 amRNSGrant of Options & PDMR Dealings
20th Nov 20174:35 pmRNSPrice Monitoring Extension
13th Nov 20177:00 amRNSDistribution Agreement Signed in Saudi Arabia
13th Oct 20173:29 pmRNSHolding(s) in Company
11th Oct 20177:00 amRNSDirector Share Purchases
11th Oct 20177:00 amRNSHolding(s) in Company
11th Oct 20177:00 amRNSEnterprise Securities Market Notice
10th Oct 20177:00 amRNSEnterprise Securities Market Notice
9th Oct 201712:13 pmRNSResult of General Meeting & Completion of Placing
21st Sep 20177:00 amRNSPlacing to raise EUR 15m
4th Sep 20177:00 amRNSInterim Results
31st Aug 20177:00 amRNSAttendance at Rodman & Renshaw Conference
30th Aug 20177:00 amRNSSenior Management Appointment
23rd Aug 20178:30 amRNSNotice of Results
25th Jul 20177:00 amRNSHighly positive long-term study results - Lojuxta
25th May 201711:49 amRNSResult of AGM
25th May 20177:00 amRNSAGM Statement
27th Apr 20177:00 amRNSStudy Results of Real-World Experience of Lojuxta

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.